Efficiency Comparison Between Methylprednisolone and Phenol 8% Treatment Using a Trans Sacral Approach - on Lower Back Pain and Limbs

Shamir Medical Center (Assaf-Harofeh)

Status and phase

Unknown

Phase 1

Conditions

Back Pain

Treatments

Drug: phenol

Study type

Interventional

Funder types

Other

Identifiers

NCT01468415

58/11

Details and patient eligibility

About

The American Society of Anesthesiologists Task Force on Management, Chronic Pain section, recommended Phenol neurolysis when other techniques have failed to provide adequate pain control. In this study we sought to Compare the pain relieve on a Lower Back and Limbs obtained from Methylprednisolone and Phenol 8% Treatment given by Trans Sacral Approach. The study includes patients who suffers from a chronic low back and/or limbs pain which were referred to be given epidural as a treatment. Control group receives 80 mg Methylprednisolone while the test group receives phenol 8%.

Enrollment

60 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: -at least 18 years of age;

chronic low back pain of at least 12 weeks duration;
patients which were diagnosed as a candidate for epidural since other techniques have failed to provide adequate pain control
Sciatica due to Lumbar Disc Herniation
Neurogenic Claudication due to Lumbar Spinal Stenosis

Exclusion Criteria: